Vor Biopharma

VORNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$1.283 B

$23.67 -0.13%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$696.0M

Loss-making

Shares outstanding

48,847,504

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#44Inhibrx BiosciencesINBX$1.30B
#45ImmaticsIMTX$1.29B
#46Vor BiopharmaVOR$1.28B
#47MeiraGTxMGTX$1.21B
#48AlvotechALVO$1.19B

Where these numbers come from

Share counts and financials for Vor Biopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.